Cargando…
Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediators of cardiovascular disease, promoting atherogenesis and unstable atherosclerotic plaque. Previous studies have shown that high levels of anti-apoA-I IgGs are independently associated with major adv...
Autores principales: | Teixeira, Priscila Camillo, Ducret, Axel, Ferber, Philippe, Gaertner, Hubert, Hartley, Oliver, Pagano, Sabrina, Butterfield, Michelle, Langen, Hanno, Vuilleumier, Nicolas, Cutler, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192480/ https://www.ncbi.nlm.nih.gov/pubmed/25170076 http://dx.doi.org/10.1074/jbc.M114.589002 |
Ejemplares similares
-
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015) -
Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives
por: Teixeira, P. C., et al.
Publicado: (2012) -
Circulating Autoantibodies Recognizing Immunodominant Epitopes From Human Apolipoprotein B Associate With Cardiometabolic Risk Factors, but Not With Atherosclerotic Disease
por: Marchini, Timoteo, et al.
Publicado: (2022) -
Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018) -
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)